Gottsegen National Cardiovascular Center
Budapest, Hungary
5 recruiting
Showing 1–7 of 7 trials
Recruiting
Phase 3
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Cardiovascular DiseasesHypertensionDiabetes Mellitus, Type 2
Boehringer Ingelheim11,800 enrolled1152 locationsNCT07064473
Recruiting
Phase 3
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Heart Failure
Boehringer Ingelheim4,200 enrolled638 locationsNCT06935370
Recruiting
Phase 3
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Heart Failure
Boehringer Ingelheim6,000 enrolled653 locationsNCT06424288
Recruiting
The Role of a Structured Patient Education Programme in the Complex Care of Patients With Heart Failure
Heart Failure
Gottsegen National Cardiovascular Institute1,000 enrolled1 locationNCT07451457
Recruiting
Not Applicable
Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease
Coronary Artery DiseaseAcute Myocardial Infarction
Population Health Research Institute5,100 enrolled113 locationsNCT05701358
Recruiting
Phase 3
Investigational Trial to Evaluate Safety and Tolerability of Treprostinil in Children Diagnosed With PAH
Pulmonary Arterial Hypertension
AOP Orphan Pharmaceuticals AG20 enrolled5 locationsNCT06350032
Recruiting
Not Applicable
Bio Refine for Functional Mitral Regurgitation - a Safety & Feasibility Study
Functional Mitral Regurgitation
Bio Refine Ltd.15 enrolled4 locationsNCT06583876